Upconversion Nanoparticles Convert NIR to Visible Light for CMOS Bioimaging

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current bioimaging methods using near-infrared (NIR) light require expensive equipment, such as indium-gallium-arsenide (InGaAs) image sensors, to capture bioimages effectively, which limits their widespread adoption due to high costs and complexity.

Innovation Solution

The use of upconversion nanoparticles (UCNPs) to convert NIR light into visible light, which is then captured using a complementary metal-oxide-semiconductor (CMOS) image sensor, specifically a silicon (Si)-based CMOS sensor, allowing for bioimage generation at a lower cost and with safer, more accessible technology.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If InGaAs image sensors are used to capture NIR light for bioimaging, then the quality and effectiveness of bioimage capture is improved, but the equipment cost and complexity increase significantly

Engineering Contradiction:
Improvebioimage capture qualityVSAvoidequipment cost and complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent introduces upconversion nanoparticles as an intermediary substance that converts NIR light into visible light. This mediator enables the use of standard CMOS image sensors instead of expensive InGaAs sensors, thereby resolving the contradiction between measurement precision and device complexity by translating the detection task into a domain where inexpensive sensors can operate effectively

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The invention changes the wavelength parameter of the light being detected. By using upconversion nanoparticles to shift NIR wavelengths to visible wavelengths, the system can utilize standard CMOS sensors that are optimized for visible light detection, thus achieving high-quality bioimaging without requiring specialized expensive sensors designed for NIR detection

Inventive Principle:
Principle #35Parameter changes

2Device complexity

If visible light is used for bioimaging, then the equipment cost is reduced and biocompatibility is improved, but the light transmission through the living body is insufficient for detecting internal phenomena

Engineering Contradiction:
Improveequipment costVSAvoidlight transmission through living body
Core Design Contradiction:
Device complexityVSReliability

Solution Approach 1:

The system uses periodic or pulsed NIR light irradiation onto the living body, with upconversion nanoparticles converting specific wavelength bands to visible light that is then captured by the CMOS sensor. This periodic action allows sufficient light transmission through tissue while maintaining detection capability

Inventive Principle:
Principle #19Periodic action

Solution Approach 2:

Upconversion nanoparticles serve as a mediator that enables visible light detection after NIR light has successfully transmitted through the living body. The nanoparticles are positioned to receive the transmitted NIR light and convert it to visible light, thus overcoming the limitation of visible light transmission while maintaining the cost benefits of visible light detection

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables the capture of bioimages similar to x-ray images using NIR light and a general CMOS image sensor, reducing equipment costs and complexity while ensuring safety, allowing for rapid and effective anatomical feature visualization without the need for expensive InGaAs sensors.

Implementation Method 1

converting the NIR light passed through the living body, into visible light using upconversion nanoparticles (UCNPs)

Methodology Applied
Scientific EffectUpconversion: Photoluminescence

Data Source

PatentUS10251556B2In vivo bioimaging method and system using near-infrared light and complementary metal-oxide-semiconductor image sensor
Publication Date: 2019.04.09 KOREA INST OF SCI & TECH
  • US10251556B2 patent drawing
  • US10251556B2 patent drawing
  • US10251556B2 patent drawing

AI summary

Provided is an in vivo bioimaging method including irradiating near-infrared (NIR) light onto a living body, converting the NIR light passed through the living body, into visible light using upconversion nanoparticles (UCNPs), and generating a bioimage of the living body by receiving the visible light using a complementary metal-oxide-semiconductor (CMOS) image sensor.